Physitrack PLC (PTRK.ST)
SEK 13.55
(5.86%)
SEK 13.55
(5.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.2 Million EUR | 3371.47% |
| 2022 | 92.31 Thousand EUR | 111.33% |
| 2021 | -815.03 Thousand EUR | -218.39% |
| 2020 | 688.4 Thousand EUR | 434.32% |
| 2019 | -205.91 Thousand EUR | 0.39% |
| 2018 | -206.71 Thousand EUR | -164.58% |
| 2017 | -78.13 Thousand EUR | 78.27% |
| 2016 | -359.62 Thousand EUR | 16.25% |
| 2015 | -429.42 Thousand EUR | -178.84% |
| 2014 | -154 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -110.76 Thousand EUR | -102.94% |
| 2024 Q2 | -471 Thousand EUR | -325.22% |
| 2023 Q4 | 3.76 Million EUR | 1666.57% |
| 2023 Q1 | -65.63 Thousand EUR | -110.22% |
| 2023 Q2 | -251.65 Thousand EUR | -283.41% |
| 2023 Q3 | -240.16 Thousand EUR | 4.57% |
| 2023 FY | 3.2 Million EUR | 3371.47% |
| 2022 Q3 | 16.65 Thousand EUR | 103.96% |
| 2022 Q1 | -145.74 Thousand EUR | -264.07% |
| 2022 FY | 92.31 Thousand EUR | 111.33% |
| 2022 Q4 | 642.38 Thousand EUR | 3756.3% |
| 2022 Q2 | -420.98 Thousand EUR | -188.85% |
| 2021 Q1 | 269.83 Thousand EUR | 8.02% |
| 2021 FY | -815.03 Thousand EUR | -218.39% |
| 2021 Q4 | 88.83 Thousand EUR | 178.14% |
| 2021 Q3 | 31.93 Thousand EUR | 102.92% |
| 2021 Q2 | -1.09 Million EUR | -506.03% |
| 2020 FY | 688.4 Thousand EUR | 434.32% |
| 2020 Q4 | 249.79 Thousand EUR | -38.25% |
| 2020 Q3 | 404.54 Thousand EUR | 84.59% |
| 2020 Q2 | 219.15 Thousand EUR | 660.89% |
| 2020 Q1 | -39.07 Thousand EUR | 0.0% |
| 2019 FY | -205.91 Thousand EUR | 0.39% |
| 2018 FY | -206.71 Thousand EUR | -164.58% |
| 2017 FY | -78.13 Thousand EUR | 78.27% |
| 2016 FY | -359.62 Thousand EUR | 16.25% |
| 2015 FY | -429.42 Thousand EUR | -178.84% |
| 2014 FY | -154 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aino Health AB (publ) | -10.66 Million SEK | 130.061% |
| Bonzun AB (publ) | 13.88 Million SEK | 76.918% |
| Kontigo Care AB (publ) | 212 Thousand SEK | -1411.71% |
| Medhelp Care Aktiebolag (publ) | -11.01 Million SEK | 129.108% |
| RaySearch Laboratories AB (publ) | 81.57 Million SEK | 96.071% |
| Surgical Science Sweden AB (publ) | 233.97 Million SEK | 98.63% |